|
|
Post by mytakeonit on May 21, 2020 16:46:38 GMT -5
Well at least he's positive. Would be bad if he was positively negative.
In any case, when the pps is at $100 ... his shares will be worth $31M+.
But, that's mytakeonit
|
|
|
|
Post by porkini on May 21, 2020 16:49:33 GMT -5
Mike said "I've invested a lot of money outside of any options and shares I get." ... Really? Does he mean he has bought more shares than is reported in the Form 4's? Is that legal? I thought all the shares he owns has to be reported in those forms. Looking back at his last two Form 4's: Derivative Securities beneficially owned: 145,275 Securities beneficially owned: 168,560 Total shares that Mike owns: 313,835 Can Mike have more (personal) shares than what we know of? In any case, from that comment, Mike seems to be satisfied with the number of shares he currently owns, so, despite that he thinks it's a good buy, he probably won't be backing his truck up to buy more soon. This is not a defense of MC, but I recall that he did make some purchases in his prior position and I believe those purchases were prior to the reverse split. Would have to research that to verify though. |
|
|
|
Post by brotherm1 on May 21, 2020 17:33:53 GMT -5
Looking closely at his words:
“Thank you for that authorized capital today.
There is no short-term need that we can see on the horizon, but we always wanta have the corporate flexibility to run the company and pursue opportunities as they exist.”
|
|
|
|
Post by peppy on May 21, 2020 17:36:01 GMT -5
Dear MannKind Shareholder and Guests,
I appreciate you taking time out of your busy schedule to listen to our update and actively participate in driving our company forward. Your votes are important regardless of how you voted for the 5 proposals as they allow us to get feedback and continue to improve our dialogue with you as we go forward into the next year. Additionally, I personally felt the ability to interact with you all during our first virtual shareholder meeting during the Q&A session was far better than the handful of questions we get in person or on the side during a live meeting and our attendance was 4X higher than a face to face meeting. I know the MannKind journey has been difficult for many of our shareholders, but as you see we are improving each quarter and despite the COVID-19 set-back for many companies I am optimistic that we made tough decisions fast on protecting our people, preserving our infrastructure we built as well as costs including salary reductions to ensure we can weather the storm. I look forward to seeing the momentum we can build coming out of this difficult situation as our sales team should mostly be back up and running by the first week of June and our employees will be returning to the office in the coming weeks. Our new board members have been active and I think you will see they bring an incredible amount of value and experience to our board. I look forward to continuing to advance our company and welcome a continuing open and constructive dialogue with our shareholders to ensure we generate positive shareholder returns going forward and continue to make MannKind very successful.
Sincerely,
Mike
Michael Castagna, PharmD
Chief Executive Officer
mannkind
30930 Russell Ranch Road, Suite 300, Westlake Village, CA 91362 USA
O 818.661.5001
|
|
|
|
Post by cretin11 on May 21, 2020 17:41:11 GMT -5
Unfortunately only 12,000 shares But better than being down :-). Very happy with the call Expect good things second half of the year and much better 2021 Just curious, what specifically were you very happy about with the call? I was hoping for better, though not surprised with the lack of good news. |
|
|
|
Post by cretin11 on May 21, 2020 17:42:51 GMT -5
Mike's last words: I'll close out the conversation saying that, obviously, shareholder return is not where we would like it. I would say that all of us are unified in our desire to progress shareholder return to be better than it has been. At the same time we had to dig the company out of a pretty deep hole over the last 3 years. That's hurt our authorized share count that's outstanding. I think you've seen Steve and I have been very prudent with those shares. We said they would last 3 years. They have lasted us 3 years that you gave us back in 2017. And, we will continue to be prudent. Thank you for that authorized capital today. There is no short-term need that we can see on the horizon, but we always wanta have the corporate flexibility to run the company and pursue opportunities as they exist. But, ya know, going into the second half here guys, we continue to see Afrezza growing. We continue to see us managing our expenses very tightly. Good positive data readouts. David's got at least 11 presentations and publications in the next 90 days, our salesforce is being expanded, the reimbursement hub, the bluhale thing. A lot of positive things going into the second half, and additionally, Trepostinil will continue to (exceed risk? ... inaudible). So when you look out, we're very excited. I think the market will finally realize the value sitting here. As we look at just Trepostinil, our royalties alone are worth probably as much as our market caps. We're going to continue to pursue increase in shareholder return as best as we can. Noone is more frustrated as me as I've invested a lot of money outside of any options and shares I get. I think this is a great buy, and I will continue to look for more opportunities to enhance that as quickly as we can, and just thank you for your patience. Just wondering why, given he “thinks this is a great buy” he hasn’t purchased shares on the open market in years? |
|
|
|
Post by mytakeonit on May 21, 2020 18:05:47 GMT -5
Well I have ...
But, that's mytakeonit
|
|
|
|
Post by sayhey24 on May 21, 2020 18:17:34 GMT -5
Unfortunately only 12,000 shares But better than being down :-). Very happy with the call Expect good things second half of the year and much better 2021 Just curious, what specifically were you very happy about with the call? I was hoping for better, though not surprised with the lack of good news. I was very happy when Mike said the double digit royalty on TrepT could be worth more than the current market cap. I think the upper projection was $1B a year. The current cap is about $285M. I was also happy Dr Kendal talked about the up coming T2 study with the Dexcom. While he could not say much he sounded excited about it. I hope he can get Kevin Sayer excited about afrezza again. |
|
|
|
Post by cretin11 on May 21, 2020 18:53:38 GMT -5
Yeah I like the TreT projection too. But unfortunately it’s just talk and we’ve heard projections before regarding Afrezza sales, none of which have come true. At least for this one it’s UTHR in charge so a better chance of coming true. As for real “news” I didn’t hear much from this meeting (but again, not a surprise).
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 21, 2020 19:06:31 GMT -5
Mike's last words: I'll close out the conversation saying that, obviously, shareholder return is not where we would like it. I would say that all of us are unified in our desire to progress shareholder return to be better than it has been. At the same time we had to dig the company out of a pretty deep hole over the last 3 years. That's hurt our authorized share count that's outstanding. I think you've seen Steve and I have been very prudent with those shares. We said they would last 3 years. They have lasted us 3 years that you gave us back in 2017. And, we will continue to be prudent. Thank you for that authorized capital today. There is no short-term need that we can see on the horizon, but we always wanta have the corporate flexibility to run the company and pursue opportunities as they exist. But, ya know, going into the second half here guys, we continue to see Afrezza growing. We continue to see us managing our expenses very tightly. Good positive data readouts. David's got at least 11 presentations and publications in the next 90 days, our salesforce is being expanded, the reimbursement hub, the bluhale thing. A lot of positive things going into the second half, and additionally, Trepostinil will continue to (exceed risk? ... inaudible). So when you look out, we're very excited. I think the market will finally realize the value sitting here. As we look at just Trepostinil, our royalties alone are worth probably as much as our market caps. We're going to continue to pursue increase in shareholder return as best as we can. Noone is more frustrated as me as I've invested a lot of money outside of any options and shares I get. I think this is a great buy, and I will continue to look for more opportunities to enhance that as quickly as we can, and just thank you for your patience. Just wondering why, given he “thinks this is a great buy” he hasn’t purchased shares on the open market in years? Why buy shares when he's about to issue himself a ton of Stock Options or Grants? |
|
|
|
Post by awesomo on May 21, 2020 19:13:10 GMT -5
Just wondering why, given he “thinks this is a great buy” he hasn’t purchased shares on the open market in years? Why buy shares when he's about to issue himself a ton of Stock Options or Grants? Signal to the shareholders that he is willing to put his own money where his mouth is. That he actually believes in the direction they're going is beneficial to shareholders, rather than just sucking up free shares/options/bonuses. |
|
|
|
Post by mango on May 21, 2020 19:39:19 GMT -5
The Veins of Gold are about to be cut wide open. 18+ publications in 2020  |
|
|
|
Post by falconquest on May 21, 2020 19:57:22 GMT -5
MNKD up $0.01 today, my shares up $0.14. Good luck!
|
|
|
|
Post by pat on May 21, 2020 20:27:02 GMT -5
Yeah I like the TreT projection too. But unfortunately it’s just talk and we’ve heard projections before regarding Afrezza sales, none of which have come true. At least for this one it’s UTHR in charge so a better chance of coming true. As for real “news” I didn’t hear much from this meeting (but again, not a surprise). It really is that bad isn’t it....guess I’ll buy some more. |
|
|
|
Post by longliner on May 21, 2020 21:51:49 GMT -5
Yeah I like the TreT projection too. But unfortunately it’s just talk and we’ve heard projections before regarding Afrezza sales, none of which have come true. At least for this one it’s UTHR in charge so a better chance of coming true. As for real “news” I didn’t hear much from this meeting (but again, not a surprise). It really is that bad isn’t it....guess I’ll buy some more. It seems to be getting bad.............just not for the long side  |
|
